Quick Answer
PTC THERAPEUTICS, INC. reported Stockholders Equity of -$205.31 million for fiscal year 2025.
PTC THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$205.31M | +81.3% |
| 2024 | -$1.10B | -34.1% |
| 2023 | -$818.55M | -135.8% |
| 2022 | -$347.09M | -24236.7% |
| 2021 | $1.44M | -99.7% |
| 2020 | $481.98M | -18.9% |
| 2019 | $594.33M | +69.5% |
| 2018 | $350.73M | +124.2% |
| 2017 | $156.44M | +30.8% |
| 2016 | $119.58M | -47.1% |
| 2015 | $226.00M | -24.3% |
| 2014 | $298.47M | +118.6% |
| 2013 | $136.54M | +237.0% |
| 2012 | -$99.64M | +58.2% |
| 2011 | -$238.60M | +12.4% |
| 2010 | -$272.33M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$155.76M | +85.2% | +24.6% |
| June 30, 2025 | -$206.55M | +78.9% | -11.2% |
| March 31, 2025 | -$185.76M | +79.2% | +83.1% |
| December 31, 2024 | -$1.10B | -34.1% | -4.1% |
| September 30, 2024 | -$1.05B | -57.2% | -7.6% |
| June 30, 2024 | -$980.18M | -69.2% | -9.7% |
| March 31, 2024 | -$893.92M | -95.4% | -9.2% |
| December 31, 2023 | -$818.55M | -135.8% | -22.0% |
- PTC THERAPEUTICS, INC. showed an increase of +81.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, PTC THERAPEUTICS, INC.’s stockholders equity has grown by 24.6% (from -$272.33 million to -$205.31 million).
- The most recent figure is from PTC THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: